Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies

Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies

Background: Human polyclonal plasma-derived hepatitis B immunoglobulin (HBIG) is currently used for immunoprophylaxis of HBV infection. The development of virus-neutralizing monoclonal antibodies (MAbs) requires the use of optimized cell culture systems supporting HBV infection.Objective: This study...

Full description

Bibliographic Details
Main Authors:	Hamzeh Sarvnaz, Sahar Asadi-Asadabad, Mohammad Mehdi Amiri, Mojgan Ghaedi, Ulrike Protzer, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, Fazel Shokri
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2022-09-01
Series:	Iranian Journal of Immunology
Subjects:	hbe antigen hbs antigen hepatitis b virus hepg2-ntcp cells
Online Access:	https://iji.sums.ac.ir/article_48688_dfc44f9e88149c1464b4e0193c1a9140.pdf

Similar Items

Status of Hepatitis Be Antigen in Chronic Hepatitis B Patients from Various Regions of Pakistan
by: Agha Babar Hussain
Published: (2017-09-01)

Hepatitis B Virus (HBV) a Severe Health Problem in Mardan, Khyber Pakhtunkhwa
by: Muhammad Waqar, et al.
Published: (2019-02-01)

Human Leukocyte Antigens Influence the Antibody Response to Hepatitis B Vaccine
by: Abdollah Jafarzadeh, et al.
Published: (2015-10-01)

Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
by: Yayun Liu, et al.
Published: (2019-04-01)

Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy
by: Chenyu Xu, et al.
Published: (2018-07-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
by: Gian Paolo Caviglia, et al.
Published: (2021-01-01)

Compositional changes of PBL population in patients with chronic hepatitis B virus infection
by: Khabiri Alireza, et al.

Effectiveness of entecavir treatment and predictive factors for virologic response
by: Carmen Monica Preda, et al.
Published: (2014-05-01)

Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment
by: Lisa Sandmann, et al.
Published: (2024-02-01)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
by: Abhishek Aggarwal, et al.
Published: (2023-04-01)

Seroprevalence of hepatitis B surface antigen and its correlation with risk factors among new recruits in Turkey
by: Tulin Altay, et al.

Faktor Risiko Hepatitis B Pada Tenaga Kesehatan Kota Pekanbaru
by: Rina Amtarina, et al.
Published: (2014-10-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
by: Taqwa Hashim, et al.
Published: (2023-12-01)

Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
by: Jianfei Long, et al.
Published: (2023-09-01)

Risk factors of hepatitis B virus surface antigen carriage and serological profile of HBsAg carriers in Lomé Togo, 2016
by: Wemboo Afiwa Halatoko, et al.
Published: (2019-01-01)

Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
by: Jianfei Long, et al.
Published: (2023-11-01)

The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
by: Ott Jördis J, et al.
Published: (2012-06-01)

Correlation between Hepatitis B surface antigen titers and HBV DNA levels
by: Amal Alghamdi, et al.
Published: (2013-01-01)

Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients
by: Licel Rodríguez, et al.
Published: (2000-04-01)

A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals
by: Jaewon Yang, et al.
Published: (2021-08-01)

Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study
by: Fumitaka Suzuki, et al.
Published: (2021-12-01)

Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir
by: Guei-Ying Chen, et al.
Published: (2015-11-01)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
by: Bonolo B. Phinius, et al.
Published: (2023-07-01)

Transformation of tobacco plant (Nicotiana tabacum L.) with the recombinant hepatitis B virus genes 35SHBsAg and 35SHBsAgER
by: Juliana Martins Ribeiro, et al.
Published: (2010-03-01)

Hepatitis B vaccination
by: ES Hajikazemi
Published: (2001-01-01)

Hepatitis In hemodialysis patients and their family (1993)
by: Farzaneh Naghlby
Published: (1999-03-01)

Commentary: Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Maria Pfefferkorn, et al.
Published: (2022-12-01)

HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment
by: Maurizio Salvadori, et al.
Published: (2020-11-01)

HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection
by: Muhammad Atif Zahoor, et al.
Published: (2022-08-01)

Silicon Nanowires Length and Numbers Dependence on Sensitivity of the Field-Effect Transistor Sensor for Hepatitis B Virus Surface Antigen Detection
by: Chi-Chang Wu
Published: (2022-02-01)

Hepatocyte Endoplasmic Reticulum Stress Inhibits Hepatitis B Virus Secretion and Delays Intracellular Hepatitis B Virus Clearance After Entecavir Treatment
by: Huan Chen, et al.
Published: (2021-02-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells
by: Sophia Schreiber, et al.
Published: (2024-04-01)

Key Factors Influencing qHBsAg Dynamics in Chronic Hepatitis B Patients During Treatment with Direct Acting Antivirals
by: Mihai Daniel DODOT, et al.
Published: (2020-03-01)

Kinetics of Hepatitis B Virus Load During Haemodialysis Sessions and α-Interferon: A Prospective Study
by: Fabrizio Fabrizi, et al.
Published: (2013-09-01)

Naturally Occurring Mutations within HBV Surface Promoter II Sequences Affect Transcription Activity, HBsAg and HBV DNA Levels in HBeAg-Positive Chronic Hepatitis B Patients
by: Ran Hao, et al.
Published: (2019-01-01)

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
by: Ferruccio Bonino, et al.
Published: (2022-07-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
by: Cheng-Yuan Peng, et al.
Published: (2015-04-01)

E2 Site Mutations in S Protein Strongly Affect Hepatitis B Surface Antigen Detection in the Occult Hepatitis B Virus
by: Hao Wang, et al.
Published: (2021-11-01)